Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-104481

General Counsel and Secretary sold 2,800 shares at $52.80 ($147,840)

  • General Counsel and Secretary acquired 5,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-10 Exercise or conversion : show line 1 in the form +5,500 90,615 D
2026-03-11 Sale : show line 2 in the form −2,800 $52.80 $147,840 87,815 D
Open-market sales · 2,800 sh · avg $52.80 · $147,840

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-10 Exercise or conversion : show line 3 in the form Restricted Stock Units −5,500 5,500 D
Loading xslF345X05/ownership.xml…